A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery

Chia Nan University of Pharmacy & Science Institutional Repository > 行政單位 > 123 > Item 310902800/34548

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34548

標題:	A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
作者:	Yang, Kai-shun Chen, Chih-Wei Yau, Ru-Bin Liang, Huang-Chien Ko, Ching-Chung Kuo, Jinn-Rung Chio, Chung-Ching Lim, Sher-Wei
貢獻者:	Dali University Chi Mei Hospital Chia Nan University of Pharmacy & Science Chi Mei Hospital Ming Chi University of Technology Chia Nan University of Pharmacy & Science Chi Mei Hospital
關鍵字:	tlif posterior lordosis anterior
日期:	2022
上傳時間:	2023-12-11 13:57:16 (UTC+8)
出版者:	BMC
摘要:	Background Transforaminal Lumbar Interbody Fusion (TLIF) is commonly associated with higher complications and longer operative time. This study aims to evaluate the effectiveness, safety, and usability of a novel minimally invasive surgery (MIS) bone graft delivery device. Methods 73 consecutive patients with lumbar spondylosis, degenerative disc disease, spondylolisthesis, scoliosis or trauma were enrolled in this randomized controlled trial. Group 1 comprised 39 patients treated with the novel MIS bone graft delivery device. Group 2 consisted of 34 patients treated with the conventional system. The primary objective of the study was the assessment of the amount of bone graft delivery using the device. The secondary objectives were the effect of the device on operative time, pain relief, disability improvement, and bone fusion grade. Results Bone delivery amount was significantly higher in the MIS device group (6.7 +/- 2.9 mL) compared to the conventional group (2.3 +/- 0.5 mL), p < 0.001. Regarding the operation time, the MIS device group was associated significantly lower duration than the conventional group (p < 0.001). After a 3-month follow-up, 39.5% of the patients in the MIS device group and 3.5% of the patients in the conventional group were observed to achieve grade I fusion (complete fusion). There was a significant difference in fusion success rates (p < 0.01). Conclusion The novel MIS bone graft delivery device was associated with successful bone delivery. Our MIS device provides promising modality with less operative time and higher bone fusion rates than conventional modalities. Trial Registration This trial was retrospectively registered on ClinicalTrials.gov (Registration date: 11/19/2021; Registration number: NCT05190055).
關聯:	BMC SURGERY, v.22, n.CB2, pp.CC2, pp.-E129,
顯示於類別:	[行政單位] 123

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	76	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....